文献速递糖尿病肥胖与代谢综合征

美洲原住民对胰岛素的生理反应揭示与糖尿病相关的代谢易感性特征

Human Physiologic Responses to Insulin in Indigenous Americans Identify a Metabolic Susceptibility Profile Linked to Diabetes.
PubMed 文献 · Diabetes Care · 2025-01-01

研究在446名美洲原住民中定义胰岛素作用/分泌的循环代谢组学特征,并在约700名美洲原住民及约2000名CARDIA研究个体中分析其与糖耐量及糖尿病的关联。胰岛素作用的代谢物评分与 incident diabetes 强烈相关,且方向与BMI和血糖相反。

要点

  • 低剂量胰岛素钳夹葡萄糖处置率(Mlow)的49种代谢物评分与 incident diabetes 相关,标准化HR 0.49(95%CI 0.35-0.69)。
  • CARDIA研究中约20年随访,Mlow代谢谱与 incident diabetes 的关联独立于BMI和血糖,HR 0.65(95%CI 0.56-0.74)。
  • EGP抑制的代谢谱与 incident diabetes 关联HR 0.66(95%CI 0.57-0.76),方向与BMI和血糖相反。

核心结论

  • 钳夹确定的胰岛素作用的代谢特征与 incident diabetes 强烈相关,提示T2D的因果-功能通路。

研究设计与样本

  • 在446名美洲原住民中定义胰岛素作用/分泌的循环代谢组学特征,包括低剂量胰岛素钳夹期间的葡萄糖处置率(Mlow)和胰岛素输注期间的内源性葡萄糖生成(EGP)抑制。
  • 在另一组约700名美洲原住民中分析代谢评分与糖耐量的关联,并在约2000名CARDIA研究个体中分析其与糖尿病/代谢风险的关联。
  • 使用组织特异性基因-代谢物映射定位代谢组学特征涉及的三甲二型糖尿病(T2D)遗传通路。

主要发现

  • 在无糖尿病的年轻美洲原住民(平均年龄29岁;平均BMI 34.9 kg/m2)中,多种胰岛素作用表型与代谢组的关联涉及脂肪酸和氨基酸代谢及炎症等机制。
  • 在发现美洲原住民人群中,基于代谢物的胰岛素作用评分与 incident diabetes 强烈相关:Mlow(49种代谢物)标准化HR 0.49(95%CI 0.35-0.69;P < 0.0001)。
  • 在另一美洲原住民人群和CARDIA组(中位年龄33岁)中,代谢评分与胰岛素抵抗指标相关(|ρ|约0.3-0.5)。
  • 在CARDIA约20年随访中,Mlow代谢谱(HR 0.65;95%CI 0.56-0.74;P < 0.0001)和EGP抑制代谢谱(HR 0.66;95%CI 0.57-0.76;P < 0.0001)与 incident diabetes 的关联独立于BMI和血糖,方向与BMI和血糖相反。
  • 代谢组学特征涉及的基因与T2D强烈相关。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To identify metabolic signatures of insulin action/secretion in Indigenous Americans (IAs) and their association with diabetes. RESEARCH DESIGN AND METHODS: We defined circulating metabolomic signatures of insulin action/secretion in 446 IAs, including glucose disposal rate during low-dose insulin clamp (Mlow) and endogenous glucose production (EGP) during insulin infusion (suppression of hepatic glucose production). We then determined associations of these metabolic scores with glucose tolerance (in a separate set of ∼700 IAs) and diabetes/metabolic risk in ∼2,000 individuals (from Coronary Artery Risk Development in Young Adults [CARDIA] study). We used tissue-specific gene-metabolite mapping to pinpoint genetic pathways of type 2 diabetes (T2D) implicated by metabolomic signatures. RESULTS: In young IAs (mean age 29 years; mean BMI 34.9 kg/m2) without diabetes, phenotype-metabolome associations across multiple insulin action phenotypes were linked to mechanisms of fatty acid and amino acid metabolism and inflammation (among others). Metabolite-based scores of insulin action were strongly related to incident diabetes in our discovery IA population (Mlow; 49 metabolites; standardized hazard ratio [HR] 0.49; 95% CI 0.35-0.69; P < 0.0001) and also associated with measures of insulin resistance in a distinct IA population (|ρ| ∼0.3-0.5 correlation) and in the CARDIA group (median age 33 years). At ∼20 years of follow-up in CARDIA, we observed a strong BMI- and glucose-independent association of the metabolite profile of Mlow (HR 0.65; 95% CI 0.56-0.74; P < 0.0001) and EGP suppression (HR 0.66; 95% CI 0.57-0.76; P < 0.0001) with incident diabetes, directionally opposed to BMI and glucose. Genes implicated by the metabolomic signatures were strongly linked to T2D. CONCLUSIONS: Metabolic signatures of clamp-determined insulin action are strongly associated with incident diabetes, suggesting causal-functional pathways of T2D.

来源:Diabetes Care,查看原文。版权归原作者所有。

引用

  1. Murthy VL, Piaggi P, Lin P, et al. Human Physiologic Responses to Insulin in Indigenous Americans Identify a Metabolic Susceptibility Profile Linked to Diabetes. Diabetes Care. 2025. PMID: 40392570. doi:10.2337/dc25-0151

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。